Delivery Order SPE2DB22D1017-SPE2DB24FG3SZ
Award Date
8/21/24
Potential Completion Date
8/22/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,843.90 Firm Fixed Price delivery order contract is for the supply of 1,000 units of the drug Tamsulosin Hydrochloride 0.4 mg Capsules, with a completion date of August 14, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The award, valued at $7,384.55, is for the delivery of Tamsulosin Hydrochloride 0.4 mg capsules in quantities of 1,000 per bottle. The contract is a Firm Fixed Price Delivery Order with a completion date of September 25, 2024. It is not a set-aside contract. Amerisourcebergen, through its Corporate Office...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,954.40. The contract was awarded by the Defense Logistics Agency (DLA) to provide 4,566,179,279 units of the drug Tamsulosin Hydrochloride 0.4 mg Capsule with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,703.94, is a delivery order for the supply of 1,000 capsules of the medication Tamsulosin Hydrochloride 0.4 mg. The contract is a firm fixed-price agreement with a completion date of May 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,295.38 firm-fixed-price delivery order is for the supply of 1,000 units of Tamsulosin Hydrochloride 0.4 mg capsules, a medication used to treat benign prostatic hyperplasia. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This federal contract award is a delivery order worth $6,657.11 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 1,000 capsules of the prescription drug Tamsulosin HCl 0.4 mg. The contract has a firm-fixed price pricing type and a completion date of September 9, 2024. It is not set aside for any specific business category. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,530.74, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of October 17, 2023 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,566,078,385 units of the medication Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $6,912.00 and a completion date of October 11, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,623.80 Firm Fixed Price Delivery Order contract is for the provision of 4,565,536 units of 0.4 mg Tamsulosin HCl capsules. The contract has an ultimate completion date of August 22, 2024 and was awarded on August 21, 2024. There was no set-aside designation for this contract. Amerisourcebergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,885.86 firm fixed-price delivery order is for the supply of 4,565,367,338 capsules of Tamsulosin Hydrochloride 0.4 milligram, a medication used to treat an enlarged prostate. The contract has an ultimate completion date of August 7, 2024 and does not utilize any set-aside designations. Amerisourcebergen has been awarded...